Physician profile
Daniel Su
NPI 1235442534
$38,862.34
in general payments reported to CMS, 2019-2025
41 companies · $23K in 2025
The $23K reported for 2025 was more than what 97% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $855 · 2020: $174 · 2021: $2,495 · 2022: $1,066 · 2023: $7,000 · 2024: $4,015 · 2025: $23K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $17K · Food and Beverage: $6,824 · Travel and Lodging: $5,536 · Education: $4,519 · Consulting Fee: $825.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $16,568.75 |
| Food and Beverage | $6,823.86 |
| Travel and Lodging | $5,535.76 |
| Education | $4,519.31 |
| Consulting Fee | $825.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teleflex LLC | $20,476.54 | 2020-2025 | Barrigel, Urolift |
| Intuitive Surgical, INC. | $5,582.23 | 2020-2023 | Da Vinci Sp, Da Vinci Surgical System |
| Procept Biorobotics Corporation | $2,780.65 | 2024-2025 | Aquabeam System |
| Histosonics, INC. | $1,651.63 | 2024-2025 | |
| Profound Medical Corp. | $1,336.68 | 2024-2025 | Tulsa-Pro |
| Abbvie INC. | $1,125.85 | 2019-2025 | Lupron Depot, Alloderm, Botox |
| Janssen Biotech, INC. | $870.16 | 2021-2025 | Erleada, Akeega, Balversa |
| Astellas Pharma US INC | $512.41 | 2019-2025 | Xtandi, Myrbetriq |
| Uromedica, Incorporated | $452.50 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $373.47 | 2021-2025 | |
| Genentech USA, INC. | $263.31 | 2023-2025 | Vabysmo |
| Pfizer INC. | $254.02 | 2019-2025 | |
| Astrazeneca Pharmaceuticals Lp | $247.21 | 2023-2024 | Lynparza |
| Merck Sharp & Dohme LLC | $241.49 | 2022-2025 | Keytruda, Lynparza, Welireg |
| Myovant Sciences INC. | $241.21 | 2021-2022 |
Show all 41 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $226.35 | 2025 | Interstim |
| Axonics, INC. | $199.60 | 2021-2022 | |
| Accord Healthcare, INC. | $184.53 | 2023-2025 | |
| Urogen Pharma, INC. | $173.90 | 2022-2023 | Jelmyto |
| Palette Life Sciences, INC. | $166.46 | 2022-2023 | |
| Edap Technomed INC | $146.42 | 2023 | |
| Dendreon Pharmaceuticals LLC | $139.41 | 2019-2025 | Provenge |
| Sumitomo Pharma America, INC. | $138.57 | 2023-2025 | Gemtesa |
| Progenics Pharmaceuticals, INC. | $137.84 | 2021-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $122.21 | 2021 | |
| Cook Medical LLC | $91.91 | 2023 | Fiber Dust |
| Tempus Ai, INC | $87.60 | 2024 | Xt Cdx |
| Antares Pharma, INC. | $77.58 | 2021 | |
| Novartis Pharmaceuticals Corporation | $76.97 | 2022-2025 | |
| Telix Pharmaceuticals | $73.58 | 2023-2025 | Illuccix |
| Blue Earth Diagnostics | $61.23 | 2024-2025 | Posluma |
| Neotract INC. | $57.93 | 2019-2020 | |
| Boston Scientific Corporation | $56.67 | 2025 | Spaceoar System |
| Urovant Sciences INC | $51.42 | 2021-2022 | |
| Allergan, INC. | $43.68 | 2019 | |
| Bioprotect Medical, INC. | $38.89 | 2024 | Bioprotect Balloon Implant System |
| Tolmar, INC. | $23.65 | 2023 | |
| Ferring Pharmaceuticals INC. | $23.01 | 2024 | Adstiladrin |
| Olympus America INC. | $20.85 | 2025 | Bovie |
| Calyxo, INC. | $16.67 | 2025 | Cvac Aspiration System |
| Foundation Medicine, INC. | $16.05 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Su listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.